Keeping up with corporate filings shouldn't be a full-time job.

Lack of time and motivation to wade through dense documents means missing out on portfolio-boosting opportunities.

Stay informed, invest smarter: AI-powered corporate filing summaries.

Setup Free Alerts → Browse Latest Filings
Sign up to stay up to date with the stocks you care about
Add RENALYTIX PLC to Feed

RENALYTIX PLC

renalytix.com

Latest news & discussion for RENALYTIX PLC:

276
1
RENALYTIX PLC FDA Approves KidneyIntelX.dkd™

Posted by AssetRoom | over 1 year ago | 0 comments

277
1
RENALYTIX PLC FDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage Kidney Disease

Posted by AssetRoom | over 1 year ago | 0 comments

278
1
RENALYTIX PLC KidneyIntelX™ Clinical Decision Impact / Validation and Health Economic Data to be Presented at Upcoming Scientific Conferences

Posted by AssetRoom | over 1 year ago | 0 comments

279
1
RENALYTIX PLC Presentation of Scientific Data

Posted by AssetRoom | over 1 year ago | 0 comments

280
1
RENALYTIX PLC New Form 6-K for Renalytix

Posted by AssetRoom | over 1 year ago | 0 comments

281
1
RENALYTIX PLC New Form 6-K for Renalytix

Posted by AssetRoom | over 1 year ago | 0 comments

282
1
RENALYTIX PLC Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2023

Posted by AssetRoom | over 1 year ago | 0 comments

283
1
RENALYTIX PLC Financial Results for Q3 of Fiscal Year 2023

Posted by AssetRoom | over 1 year ago | 0 comments

284
1
RENALYTIX PLC Result of General Meeting

Posted by AssetRoom | over 1 year ago | 0 comments

285
1
RENALYTIX PLC Renalytix to Report Third Quarter Fiscal Year 2023 Financial Results on June 9

Posted by AssetRoom | over 1 year ago | 0 comments

286
1
RENALYTIX PLC Notice of Q3 Results

Posted by AssetRoom | over 1 year ago | 0 comments

287
1
RENALYTIX PLC Renalytix selects EVERSANA® to expand commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes

Posted by AssetRoom | over 1 year ago | 0 comments

288
1
RENALYTIX PLC EVERSANA® partnership for KidneyIntelX

Posted by AssetRoom | over 1 year ago | 0 comments

289
1
RENALYTIX PLC New Form 6-K for Renalytix

Posted by AssetRoom | over 1 year ago | 0 comments

290
1
RENALYTIX PLC Expansion of insurance coverage for KidneyIntelX

Posted by AssetRoom | over 1 year ago | 0 comments

291
1
RENALYTIX PLC New Form 6-K for Renalytix

Posted by AssetRoom | over 1 year ago | 0 comments

292
1
RENALYTIX PLC New Form 6-K for Renalytix

Posted by AssetRoom | over 1 year ago | 0 comments

293
1
RENALYTIX PLC New Form EFFECT for Renalytix

Posted by AssetRoom | over 1 year ago | 0 comments

294
1
RENALYTIX PLC Notice of GM and Posting of Circular

Posted by AssetRoom | over 1 year ago | 0 comments

295
1
RENALYTIX PLC New Form 424B3 for Renalytix

Posted by AssetRoom | over 1 year ago | 0 comments

296
1
RENALYTIX PLC New Form F-3 for Renalytix

Posted by AssetRoom | over 1 year ago | 0 comments

297
1
RENALYTIX PLC New Published Real-World Evidence Shows KidneyIntelX™ Utility

Posted by AssetRoom | over 1 year ago | 0 comments

298
1
RENALYTIX PLC Real-World Evidence Shows KidneyIntelX™ Utility

Posted by AssetRoom | over 1 year ago | 0 comments

299
1
RENALYTIX PLC Data Supportive of KidneyIntelX Utility in Minorities and Veterans to Be Presented at the National Kidney Foundation Spring Clinical Meeting

Posted by AssetRoom | over 1 year ago | 0 comments

300
1
RENALYTIX PLC Positive Data Release at NKF Conference

Posted by AssetRoom | over 1 year ago | 0 comments